Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2.11Prev. Close
2.25Volume
11,033Total traded value
0.00 CrUpper Circuit
2.36Lower Circuit
2.14Fundamentals
| Market Cap | ₹5.36Cr |
| ROE | 3.71% |
| P/E Ratio(TTM) | -1.07 |
| EPS(TTM) | -2.11 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.98 |
| Book Value | -55.79 |
| Debt to Equity | -1.05 |
| Face Value | 10 |
Understand Fundamentals
Financials
About KOBO Biotech
Kobo Biotech Limited is a customer-focused company that manufactures active pharmaceutical ingredients (API), the key components in medicines, using fermentation technology. The company strives to achieve fairness for all its stakeholders and aims to enhance long-term value for its shareholders through ethical practices. As of March 2022, over 99.42% of the company's paid-up share capital was held in dematerialized, or electronic, form.;
| Parent Organisation | KOBO Biotech Limited |
| Managing Director | Mr. Ajit Kamath |
| BSE Symbol | 531541 |
Shareholding Pattern
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 104.06 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.19 | ||
| Wockhardt | NA (0.00%) | -198.91 |